Literature DB >> 18692123

Immunomodulatory and antitumor activity of triterpenoid fractions from the rhizomes of Astilbe chinensis.

Jue Tu1, Hong-Xiang Sun, Yi-Ping Ye.   

Abstract

AIM OF THE STUDY: The objectives of this study were to evaluate the in vivo antitumor potential of the triterpenoid fraction from the rhizomes of Astilbe chinensis (Saxifragaceae) (Saxifragaceae) (ATF) and to elucidate its immunological mechanisms by determining its effects on the growth of mouse transplanted tumors and the immune response in naïve and tumor-bearing mice.
MATERIALS AND METHODS: The mice inoculated with mouse tumor cell lines were treated per os with ATF at the doses of 20, 40, 60 mg/kg for 10 days. The effects of ATF on the growth of transplantable tumor, splenocyte proliferation, the activity of natural killer (NK) cells, and production of interleukin-2 (IL-2) from splenocytes in tumor-bearing mice were measured. Meanwhile, the effects of ATF on 2,4-dinitrofluorobenzene (DNFB)-induced delayed type hypersensitivity (DTH) reaction and the sheep red blood cell (SRBC)-induced antibody response in naïve mice were also studied.
RESULTS: ATF could not only significantly inhibit the growth of mice transplantable tumor, but also remarkably increase splenocytes proliferation, NK cells activity, and the level of IL-2 secreted by splenocytes in tumor-bearing mice, promote the DTH reaction and enhance anti-SRBC antibody level in naïve mice, which indicated that the ATF could improve both specific and non-specific cellular and humoral immune response.
CONCLUSIONS: The antitumor activity of ATF might be achieved by improving immune response, and ATF could act as antitumor agent with immunomodulatory activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692123     DOI: 10.1016/j.jep.2008.07.007

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice.

Authors:  Zheng-Shun Wen; Ying-Lei Xu; Xiao-Ting Zou; Zi-Rong Xu
Journal:  Mar Drugs       Date:  2011-06-14       Impact factor: 6.085

2.  Improved Chemotherapeutic Activity by Morus alba Fruits through Immune Response of Toll-Like Receptor 4.

Authors:  Bo Yoon Chang; Seon Beom Kim; Mi Kyeong Lee; Hyun Park; Sung Yeon Kim
Journal:  Int J Mol Sci       Date:  2015-10-13       Impact factor: 5.923

3.  Evaluation of in vitro and in vivo antileishmanial potential of bergenin rich Bergenia ligulata (Wall.) Engl. root extract against visceral leishmaniasis in inbred BALB/c mice through immunomodulation.

Authors:  Rupinder Kaur; Sukhbir Kaur
Journal:  J Tradit Complement Med       Date:  2017-06-27

4.  Synergistic radiation protective effect of purified Auricularia auricular-judae polysaccharide (AAP IV) with grape seed procyanidins.

Authors:  Haina Bai; Zhenyu Wang; Jie Cui; Keli Yun; Hua Zhang; Rui Hai Liu; Ziluan Fan; Cuilin Cheng
Journal:  Molecules       Date:  2014-12-11       Impact factor: 4.411

5.  Immune-enhancing effects of anionic macromolecules extracted from Codium fragile on cyclophosphamide-treated mice.

Authors:  Chaiwat Monmai; SangGuan You; Woo Jung Park
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

6.  Immunomodulatory activity of a fructooligosaccharide isolated from burdock roots.

Authors:  Xiu-Juan Zhang; Shao-Fang Liu; Yan Lu; Jian-Yue Wang; Kao-Shan Chen
Journal:  RSC Adv       Date:  2019-04-09       Impact factor: 4.036

Review 7.  Terpenoids' anti-cancer effects: focus on autophagy.

Authors:  Chirine El-Baba; Amro Baassiri; Georges Kiriako; Batoul Dia; Sukayna Fadlallah; Sara Moodad; Nadine Darwiche
Journal:  Apoptosis       Date:  2021-07-16       Impact factor: 4.677

8.  The Inhibitory Effect of 3 β -Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells through JNK and Akt Signaling Pathway.

Authors:  Juanjuan Wang; Xiangfeng Chen; Zhihua Zhou; Jinhui Li; Hongxiang Sun
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-27       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.